- Home
- ESPR vs MIN Comparison
ESPR vs MIN Comparison
Compare ESPR & MIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- MIN
- Stock Information
- Founded
- ESPR 2008
- MIN 1988
- Country
- ESPR United States
- MIN United States
- Employees
- ESPR N/A
- MIN N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- MIN Trusts Except Educational Religious and Charitable
- Sector
- ESPR Health Care
- MIN Finance
- Exchange
- ESPR Nasdaq
- MIN Nasdaq
- Market Cap
- ESPR 305.0M
- MIN 306.1M
- IPO Year
- ESPR 2013
- MIN N/A
- Fundamental
- Price
- ESPR $1.69
- MIN $2.69
- Analyst Decision
- ESPR Buy
- MIN
- Analyst Count
- ESPR 7
- MIN 0
- Target Price
- ESPR $6.36
- MIN N/A
- AVG Volume (30 Days)
- ESPR 4.2M
- MIN 331.0K
- Earning Date
- ESPR 03-04-2025
- MIN 01-01-0001
- Dividend Yield
- ESPR N/A
- MIN 7.31%
- EPS Growth
- ESPR N/A
- MIN N/A
- EPS
- ESPR N/A
- MIN 0.08
- Revenue
- ESPR $332,314,000.00
- MIN N/A
- Revenue This Year
- ESPR $5.51
- MIN N/A
- Revenue Next Year
- ESPR $1.42
- MIN N/A
- P/E Ratio
- ESPR N/A
- MIN $33.38
- Revenue Growth
- ESPR 185.66
- MIN N/A
- 52 Week Low
- ESPR $1.47
- MIN $2.52
- 52 Week High
- ESPR $3.94
- MIN $2.88
- Technical
- Relative Strength Index (RSI)
- ESPR 49.78
- MIN 47.44
- Support Level
- ESPR $1.47
- MIN $2.66
- Resistance Level
- ESPR $1.61
- MIN $2.73
- Average True Range (ATR)
- ESPR 0.12
- MIN 0.03
- MACD
- ESPR 0.02
- MIN -0.00
- Stochastic Oscillator
- ESPR 56.41
- MIN 31.67
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About MIN MFS Intermediate Income Trust
MFS Intermediate Income Trust is a diversified closed-end management investment company. The fund's investment objective is to seek high current income but may also consider capital appreciation. It invests the assets in debt instruments. Its portfolio of investments comprises of different sector investments such as the automotive, chemicals, energy, food and beverages, insurance, and other sectors.